SCHEMBL15833944

SCHEMBL15833944

COCC(=O)NC[C@@H](O)CN(C)C

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.37
HPGD P15428 3/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PRMT5 O14744 5/20 0.32
WDR77 Q9BQA1 2/20 0.32
SPR P35270 1/20 0.32
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15833974 1.00 LMNA (0.40) LMNAGAAHPGDMAPTTSHR
SCHEMBL15833948 0.85 LMNA (0.38) LMNAHPGDMAPTTSHRSMN1; SMN2
SCHEMBL15833946 0.85 LMNA (0.38) LMNAHPGDMAPTTSHRSMN1; SMN2
SCHEMBL8538369 0.85 TSHR (0.39) LMNAHPGDMAPTTSHRHSD17B10
SCHEMBL8587563 0.84 GAA (0.38) LMNAGAAHPGDMAPTTSHR
SCHEMBL15833991 0.83 L3MBTL1 (0.44) LMNAGAAHPGDMAPTTSHR
SCHEMBL15835857 0.83 L3MBTL1 (0.44) LMNAGAAHPGDMAPTTSHR
SCHEMBL15834000 0.82 LMNA (0.37) LMNAHPGDMAPTPRMT5WDR77
SCHEMBL12732931 0.79 LMNA (0.45) LMNAHPGDTSHRHSD17B10SMN1; SMN2
SCHEMBL23866537 0.79 MEN1 (0.40) LMNAGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014100764-A2 METHODS OF INHIBITING PRMT5 Epizyme, Inc. (US) 2014-06-26 WO disclosed
WO-2014100734-A1 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-06-26 WO disclosed
WO-2014100730-A1 PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF Epizyme, Inc. (US) 2014-06-26 WO disclosed